Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for MLAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 -6.49%
December 31, 2025 5.57%
September 30, 2025 4.08%
June 30, 2025 7.96%
March 31, 2025 -11.45%
December 31, 2024 -2.67%
September 30, 2024 5.93%
June 30, 2024 5.82%
March 31, 2024 -432.2%
December 31, 2023 3.96%
September 30, 2023 -2.31%
June 30, 2023 -1.08%
March 31, 2023 1.10%
December 31, 2022 0.83%
September 30, 2022 2.22%
June 30, 2022 -2.85%
March 31, 2022 -3.03%
December 31, 2021 -3.77%
September 30, 2021 10.38%
June 30, 2021 5.71%
March 31, 2021 10.33%
December 31, 2020 -13.29%
September 30, 2020 8.41%
June 30, 2020 4.06%
March 31, 2020 -4.54%
Date Value
December 31, 2019 -14.23%
September 30, 2019 12.42%
June 30, 2019 17.49%
March 31, 2019 5.30%
December 31, 2018 3.22%
September 30, 2018 4.00%
June 30, 2018 16.82%
March 31, 2018 15.83%
December 31, 2017 -46.83%
September 30, 2017 10.25%
June 30, 2017 6.69%
March 31, 2017 14.99%
December 31, 2016 13.64%
September 30, 2016 9.66%
June 30, 2016 9.14%
March 31, 2016 16.08%
December 31, 2015 13.04%
September 30, 2015 8.05%
June 30, 2015 12.70%
March 31, 2015 12.06%
December 31, 2014 13.48%
September 30, 2014 16.50%
June 30, 2014 11.47%
March 31, 2014 22.03%
December 31, 2013 13.31%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 18.47%
Bio-Rad Laboratories, Inc. -89.02%
Bruker Corp. 1.91%
Danaher Corp. 17.29%
Harvard Bioscience, Inc. -16.50%